NFKB1 and immune system disorder: However, in T21, where chronic inflammation and immune dysfunction are prevalent, the increased NF-κB levels—particularly at higher doses like 50 μM—may reflect a complex interplay between elevated total oxidant capacity (TOC) and an impaired immune response.